241 related articles for article (PubMed ID: 17380077)
1. Expression of ErbB receptor proteins and TGF-alpha during diethylnitrosamine-induced hepatocarcinogenesis in the rat liver.
Lee TY; Kim KT; Han SY
Korean J Hepatol; 2007 Mar; 13(1):70-80. PubMed ID: 17380077
[TBL] [Abstract][Full Text] [Related]
2. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis.
Schiffer E; Housset C; Cacheux W; Wendum D; Desbois-Mouthon C; Rey C; Clergue F; Poupon R; Barbu V; Rosmorduc O
Hepatology; 2005 Feb; 41(2):307-14. PubMed ID: 15660382
[TBL] [Abstract][Full Text] [Related]
3. [Differentially expressed proteins in the precancerous stage of rat hepatocarcinogenesis induced by diethylnitrosamine].
Liang HJ; Wei W; Kang XN; Guo K; Cao J; Su JJ; Yang C; Ou C; Li Y; Liu YK
Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):669-74. PubMed ID: 19785954
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-alpha in carcinogen-induced F344 rat hepatic foci.
Steinmetz KL; Klaunig JE
Toxicol Appl Pharmacol; 1996 Sep; 140(1):131-45. PubMed ID: 8806879
[TBL] [Abstract][Full Text] [Related]
5. An acyclic retinoid, NIK-333, inhibits N-diethylnitrosamine-induced rat hepatocarcinogenesis through suppression of TGF-alpha expression and cell proliferation.
Kagawa M; Sano T; Ishibashi N; Hashimoto M; Okuno M; Moriwaki H; Suzuki R; Kohno H; Tanaka T
Carcinogenesis; 2004 Jun; 25(6):979-85. PubMed ID: 14742314
[TBL] [Abstract][Full Text] [Related]
6. Possible tumor development from double positive foci for TGF-alpha and GST-P observed in early stages on rat hepatocarcinogenesis.
Kitano M; Wada J; Ariki Y; Kato M; Wanibuchi H; Morimura K; Hidaka T; Hosoe K; Fukushima S
Cancer Sci; 2006 Jun; 97(6):478-83. PubMed ID: 16734725
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-alpha expression is altered during experimental hepatocarcinogenesis.
Burr AW; Toole K; Mathew J; Hines JE; Chapman C; Burt AD
J Pathol; 1996 Jul; 179(3):276-82. PubMed ID: 8774483
[TBL] [Abstract][Full Text] [Related]
8. Chronic ethanol intake promotes double gluthatione S-transferase/transforming growth factor-alpha-positive hepatocellular lesions in male Wistar rats.
Pires PW; Furtado KS; Justullin LA; Rodrigues MA; Felisbino SL; Barbisan LF
Cancer Sci; 2008 Feb; 99(2):221-8. PubMed ID: 18271918
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-alpha expression in rat experimental hepatocarcinogenesis.
Pérez-Tomás R; Mayol X; Culleré X; Díaz Ruiz C; Domingo J
Histol Histopathol; 1992 Jul; 7(3):457-62. PubMed ID: 1504466
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
Piyathilake CJ; Frost AR; Manne U; Weiss H; Bell WC; Heimburger DC; Grizzle WE
Clin Cancer Res; 2002 Mar; 8(3):734-44. PubMed ID: 11895903
[TBL] [Abstract][Full Text] [Related]
11. Unique carboxyl-terminal sequences of wild type and alternatively spliced variant forms of transforming growth factor-alpha precursors mediate specific interactions with ErbB4 and ErbB2.
Xu X; Kelleher KF; Liao J; Creek KE; Pirisi L
Oncogene; 2000 Jun; 19(28):3172-81. PubMed ID: 10918572
[TBL] [Abstract][Full Text] [Related]
12. Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver.
Moser GJ; Wolf DC; Goldsworthy TL
Toxicol Pathol; 1997; 25(3):275-83. PubMed ID: 9210259
[TBL] [Abstract][Full Text] [Related]
13. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
[TBL] [Abstract][Full Text] [Related]
14. [The expression of mutant p53 (mp53) protein in rat hepatic preneoplastic lesions induced by diethylnitrosamine (DEN)].
Zhu H; Zhang X; Chen Y
Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):22-4. PubMed ID: 10743048
[TBL] [Abstract][Full Text] [Related]
15. Transferrin and transferrin receptor gene expression and iron uptake in hepatocellular carcinoma in the rat.
Pascale RM; De Miglio MR; Muroni MR; Simile MM; Daino L; Seddaiu MA; Pusceddu S; Gaspa L; Calvisi D; Manenti G; Feo F
Hepatology; 1998 Feb; 27(2):452-61. PubMed ID: 9462644
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analyses at the late stage of tumor promotion by oxfendazole in a rat hepatocarcinogenesis model.
Dewa Y; Nishimura J; Jin M; Kawai M; Saegusa Y; Kenmochi S; Shimamoto K; Harada T; Shibutani M; Mitsumori K
Arch Toxicol; 2011 Feb; 85(2):155-62. PubMed ID: 20502879
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of liver carcinogenesis in Wistar rats by consumption of an aqueous extract from leaves of Ardisia compressa.
González de Mejía E; Ramírez-Mares MV; Arce-Popoca E; Wallig M; Villa-Treviño S
Food Chem Toxicol; 2004 Mar; 42(3):509-16. PubMed ID: 14871594
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of direct lineage between hepatocytes and hepatocellular carcinoma in diethylnitrosamine-treated rats.
Bralet MP; Pichard V; Ferry N
Hepatology; 2002 Sep; 36(3):623-30. PubMed ID: 12198654
[TBL] [Abstract][Full Text] [Related]
19. Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain.
De Miglio MR; Simile MM; Muroni MR; Pusceddu S; Calvisi D; Carru A; Seddaiu MA; Daino L; Deiana L; Pascale RM; Feo F
Mol Carcinog; 1999 May; 25(1):21-9. PubMed ID: 10331741
[TBL] [Abstract][Full Text] [Related]
20. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
